![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Göke R. Gruenberger J. B. Bader G. Dworak M.
Publisher: Informa Healthcare
ISSN: 1473-4877
Source: Current Medical Research and Opinion, Vol.30, Iss.5, 2014-05, pp. : 785-789
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Empagliflozin as add‐on to metformin in people with Type 2 diabetes
DIABETIC MEDICINE, Vol. 32, Iss. 12, 2015-12 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 20, Iss. 3, 2018-03 ,pp. :